新闻
2024-02-26
临床申请细胞疗法免疫疗法孤儿药
2024-02-26
传奇生物获得CHMP对CARVYKTI®用于前线治疗的积极意见
细胞疗法免疫疗法上市批准临床结果
2024-02-26
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
临床研究
2024-02-26
Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update
临床结果临床2期ASCO会议
2024-02-26
引进/卖出抗体药物偶联物医药出海
2024-02-26
先必新®舌下片III期临床研究于JAMA杂志发表
临床结果临床成功申请上市
2024-02-26
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy
临床3期上市批准临床结果孤儿药加速审批
2024-02-26
Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
上市批准临床结果引进/卖出
2024-02-26
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
AACR会议临床申请
2024-02-26
Dupixent® sBLA accepted for FDA Priority Review for treatment of COPD with type 2 inflammation
优先审批上市批准临床结果